呼吸道病毒多重分子检测重复检测的最佳时机
该研究分析5年呼吸道病毒多重核酸检测结果,发现重复检测中71%结果无变化,20天内重复检测结果改变几率仅为21-90天的0.52倍(95%CI 0.43-0.62,P<0.001),提示短间隔重复检测冗余且增加成本,建议实验室管理限制不必要的重复检测。
要点
- 20天内重复检测结果改变几率显著低于21-90天(OR=0.52,95%CI 0.43-0.62,P<0.001)。
- 71%的重复检测结果无变化,初阴多保持阴性,初阳多保持阳性至11-15天。
- 结果改变几率在20天后趋于稳定,建议避免20天内重复检测。
核心结论
- 短间隔重复多重呼吸道病毒检测常导致冗余结果并增加成本。
- 20天内重复鼻咽拭子检测结果改变很少,结果改变几率在20天后趋于稳定。
研究设计与样本
- 回顾性分析5年呼吸道病毒多重NAAT结果,靶向14种病毒。
- 纳入21,819份鼻咽拭子(来自16,779人),其中2,583份(12%)为90天内重复检测(来自1,473例患者)。
- 采用逻辑回归比较不同时间间隔结果改变的比值比。
主要发现
- 8,807份样本(40%)至少一种病毒阳性。
- 重复检测中71%(1,833份)结果无变化。
- 初阴通常保持阴性,初阳多保持阳性至11-15天。
- 20天内重复检测结果改变比值比为0.52(95%CI 0.43-0.62,P<0.001),参照组为21-90天。
临床怎么用
- 建议避免20天内重复检测呼吸道病毒多重NAAT,以减少冗余和成本。
- 可依据此结果制定实验室管理策略,限制不必要的检测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Determining whether and when multiplex nucleic acid amplification tests (NAATs) for respiratory viruses should be repeated is difficult. We analyzed 5 years of results for a multiplex NAAT targeting 14 respiratory viruses, to determine how often repeat tests were ordered and the time period in which results were likely to change. Results for NAATs performed on nasopharyngeal specimens and repeated within 90 days after initial testing were analyzed. Logistic regression models were used to compare time periods between tests with respect to the odds of a change in the sample result. During the study period, 21,819 nasopharyngeal specimens from 16,779 individuals were submitted. Of these, 8,807 samples (40%) were positive for at least one viral pathogen. Among this cohort, 2,583 specimens (12%) collected from 1,473 patients (9%) were repeat tests performed within 90 days after an initial test. If repeated within 90 days, 71% of tests (1,833 tests) did not have a change in result. Initially negative tests typically remained negative, whereas initially positive tests mostly remained positive until 11 to 15 days. The odds of result change plateaued after 20 days. The odds of result change for tests repeated within 20 days were only 0.52 times the odds (95% confidence interval, 0.43 to 0.62) for those repeated at 21 to 90 days (P < 0.001). Multiplex tests for respiratory viruses that are repeated within short periods lead to redundant results at additional costs. Repeat testing of nasopharyngeal specimens before 20 days demonstrates little change. These results provide a vital component for use in laboratory stewardship to curtail unnecessary respiratory viral testing.
引用
- Mandelia Y, Procop GW, Richter SS, et al. Optimal Timing of Repeat Multiplex Molecular Testing for Respiratory Viruses. J Clin Microbiol. 2020. PMID: 31748321. doi:10.1128/JCM.01203-19
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。